The Tick App: Changing Behaviors With Educational Messaging
Launched by UNIVERSITY OF WISCONSIN, MADISON · Mar 11, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Tick App study is looking into how people interact with ticks and what factors might increase the risk of tick bites and tick-borne diseases, like Lyme disease. This research will take place primarily in Wisconsin and aims to enroll up to 1,000 participants. The main tool they will use is an app that allows participants to log their daily activities for a week, helping researchers understand how often people encounter ticks and how they can better protect themselves.
To be eligible for this study, you should be between 65 and 74 years old and willing to complete daily logs in the Tick App for seven days. It's important that you can provide informed consent, meaning you understand what the study involves and agree to participate. If you’re interested, you should know that this is a great opportunity to contribute to important research about tick safety and prevention in your community!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Will to participate in 7 days worth of daily activity logs within the Tick App.
- • be able and willing to provide informed consent
- Exclusion Criteria:
- • Completes less than 7 days worth of daily logs or completes 7+ daily logs but not within 12 months.
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
East Lansing, Michigan, United States
Urbana, Illinois, United States
Pullman, Washington, United States
Patients applied
Trial Officials
Susan Paskewitz
Principal Investigator
University of Wisconsin, Madison
Lyric Bartholomay
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported